Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Oher GLP-1 like lixsenatide (Sanofi Aventis, trade name Lyxumia) and albiglutide (GlaxoSmithKline, trade names Epezan and Tanseum) are currently approved or are under consideration for diabetes treatment (Ladenheim, 2015)
There is also a deeper pharmaceutical and patent strategy behind this move
Studies have observed that exposing aging mice to the DRI peptide reportedly resulted in improved tissue regeneration and health span
This is a significant development because it is the first oral GLP-1 medication with an FDA-approved indication for weight management
US$ 29.66
US$ 24.60
US$ 27.67
US$ 22.29
US$ 21.34
